Eunice S. Wang, MD, highlights the importance of biomarkers and MRD testing for optimal treatment of patients with AML.
Amir Fathi, MD, provides expert insights and guidance on the best strategies to optimize treatment for patients with FLT3-mutant or IDH-mutant AML.
Jeffrey E. Lancet, MD, provides expert insights and guidance on the best strategies to treat elderly and other patients with newly diagnosed AML.
Farhad Ravandi, MD, examines current and investigational AML treatment approaches using antibody-drug conjugates and other immunotherapies.
Download this PDF guide to best practices for the management of patients with acute myeloid leukemia.